NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,677 | +3.5% | 28,000 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $16,106 | +19304.8% | 28,000 | -76.3% | 0.01% | -81.5% |
| Q1 2023 | $83 | -68.9% | 118,000 | 0.0% | 0.06% | -65.6% |
| Q4 2022 | $267 | -99.9% | 118,000 | -7.8% | 0.19% | -34.6% |
| Q3 2022 | $410,000 | -15.6% | 128,000 | 0.0% | 0.29% | -18.4% |
| Q2 2022 | $486,000 | -29.6% | 128,000 | 0.0% | 0.35% | -28.8% |
| Q1 2022 | $690,000 | -48.9% | 128,000 | +28.0% | 0.50% | -42.9% |
| Q4 2021 | $1,351,000 | +4.5% | 100,000 | +38.9% | 0.87% | -1.0% |
| Q3 2021 | $1,293,000 | +4.6% | 72,000 | 0.0% | 0.88% | +19.1% |
| Q2 2021 | $1,236,000 | -32.8% | 72,000 | -21.7% | 0.74% | -32.3% |
| Q1 2021 | $1,840,000 | +444.4% | 92,000 | +868.4% | 1.09% | +430.1% |
| Q2 2019 | $338,000 | +6.0% | 9,500 | 0.0% | 0.21% | +3.0% |
| Q1 2019 | $319,000 | +2.2% | 9,500 | 0.0% | 0.20% | -32.2% |
| Q4 2018 | $312,000 | -46.1% | 9,500 | 0.0% | 0.30% | -21.1% |
| Q3 2018 | $579,000 | +24.8% | 9,500 | 0.0% | 0.37% | +18.7% |
| Q2 2018 | $464,000 | – | 9,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |